Thymus Lymphoma — Trials

Thymus Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

127 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 33
Ph III recruiting: 0
Growth YoY: —
Industry share: 24%
Top sponsor: University of Washington
Termination share: 30.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04503538	Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity	withdrawn	N/A	0	Wake Forest University Health SciencesOTHER	0	Oct 23, 2020	clinicaltrials

Data updated 22 days agoSource updated Oct 23, 2020source: clinicaltrials